1895 |
February |
Masujiro Takada established a household medicine company in Yodobashi Ward (Currently Shinjuku-ku) in Tokyo. |
1928 |
November |
Name of the company was changed into Takata Seiyaku Co., Ltd. |
Genbei Takada was appointed as representative director and president. |
1945 |
September |
Relocated Head office to Terajima-cho, Mukojima-ku (Currently Higashimukojima, Sumida-ku) in Tokyo. |
1954 |
December |
Kiichi Sekine was appointed as representative director and president. |
1960 |
September |
Inosuke Takada was appointed as representative director and president. |
1964 |
February |
The Omiya Plant was constructed in Onari-cho, Omiya City (Currently Omiya-ku, Saitama City), Saitama Prefecture. |
1973 |
January |
Formed marketing alliance with Nippon Kayaku Co., Ltd. |
1975 |
December |
Formed marketing alliance with Shionogi & Co., Ltd. |
1977 |
July |
The Omiya Plant (GMP-certified plant) was moved into Miyamae-cho, Omiya City (Currently Nishi-ku, Saitama City), Saitama Prefecture. |
1980 |
July |
Head office was moved into Torigoe, Taito-ku, Tokyo. |
October |
Formed marketing alliance with Yakult Honsha Co., Ltd. (health drink) |
1985 |
June |
Shigeki Takada was appointed as representative director and president. |
1994 |
January |
The Satte Laboratory and Plant were constructed in Satte City, Saitama Prefecture. |
2002 |
February |
Completion of the Omiya Plant II. |
2006 |
December |
Formed marketing alliance with Yakult Honsha Co., Ltd. (Medical supplies) |
2007 |
March |
Completion of the Kitasaitama Plant. |
2010 |
December |
Shigeki Takada was appointed as chairman of the board directors and representative director. |
Hiroki Takada was appointed as representative director and president. |
2014 |
May |
Completion of the Satte Plant, dedicated production of solid oral forms, and Logistic Center in Satte City, Saitama Prefecture. |
2016 |
April |
Head office was moved into Minami-ku, Saitama City, Saitama Prefecture. |
June |
Establishment of Tokyo branch office |
2022 |
May |
Formed capital and marketing alliance with CEOLIA Pharma Co.,Ltd. |
2023 |
July |
Completion of the Kitasaitama Plant II. |
October |
Concluded a memorandum of understanding with Yakult Honsha Co., Ltd. regarding the transfer and succession of sales of Elplat and other cancer-related pharmaceuticals (sales to commence April 2024). |
December |
Established TAKATA Healthcare Solutions Co.,Ltd. |
2024 |
January |
Establishment of Saitama branch office |